COVID-19 Vaccines
This month, three major vaccine developers reported preliminary data showing their covid-19 vaccines were highly successful in protecting participants in late-stage clinical trials. This news may feel like a lone bright spot in a year of ugly - and deadly - pandemic-related headlines. In a matter of weeks, the Food and Drug Administration could sign off on emergency use of these vaccines, making them available to vulnerable populations, health care and frontline workers and eventually the general population. So how does the vaccine work? How quickly can we get it from manufacturing facilities to end users? What are the risks and side effects? How can we trust it's safe? Major explores these questions and more this week on "The Debrief."
